Difficulty chewing after Botox: why it happens, how long it lasts
A jaw that tires quickly, weaker chewing or discomfort when chewing food after a botulinum toxin injection in the masseters is the side effect most often reported in trials. It is usually mild and temporary. Here is its cause, how long it lasts, what to avoid and when to see a doctor.
The masseters are the powerful muscles at the angle of the jaw, used to clench the teeth and chew10. When they are very developed, some people have them injected with botulinum toxin to slim the lower face. In France, no label provides for this area: it is an off-label use, for every toxin6,7. A muscle relaxed to reduce its volume also loses some of its strength, which can make chewing less efficient. This is one of the jaw problems after a masseter injection. Here are the answers to the seven questions people ask most often.
Why is chewing difficult?
Botulinum toxin blocks transmission between the nerve and the injected muscle. In the masseter, this relaxation is exactly what is sought, since over time it reduces the volume of the muscle and the width of the lower face1,10. But a weakened masseter also clenches less strongly: chewing takes more effort, the jaw tires more quickly, and discomfort or pain in the jaw may appear.
Trials group these complaints under the term "mastication disorder". In the phase 3 trial published in 2026, funded by the manufacturer of the toxin studied, it covered masseter and jaw fatigue or pain, and weakness when chewing1. In the phase 2b trial, also funded by the manufacturer, it was described as difficulty chewing, needing to chew more or chewing fatigue2.
It is the most common treatment-related side effect in the phase 3 trial: 3.5% of treated people, compared with none on placebo, and 4.2% counting all chewing problems that occurred during the trial1. In the phase 2b trial, 2.9% of treated people were affected, slightly more often at the higher dose (4.1%) than at the lower one (1.9%)2. A retrospective single-centre series gives a much higher figure: a temporary decrease in chewing strength was reported after 611 of 2,036 sessions, or 30%3. This series noted complaints at every session during follow-up3, which is not comparable with the events reported in trials.
How soon after the injection does it appear?
It appears as the effect of the toxin sets in. A review of 36 articles on the side effects of masseter injections states that most of them appear within 2 to 4 weeks of the injection4. A study that measured maximal bite force found it clearly reduced 3 months after an injection5.
How long does it last?
Usually a few weeks. In the phase 2b trial, all chewing problems resolved within a month of their onset2. In the phase 3 trial, treatment-related side effects were generally mild and resolved spontaneously1. The review of 36 articles states that most side effects of masseter injections disappear within 12 weeks4.
Measured bite force recovers more slowly: in a study of 20 treated people, compared with 12 untreated people, it was clearly reduced at 3 months and no longer significantly reduced at 6 months5. This study was partly funded by the manufacturer of the toxin used5. To understand what the duration of action depends on, see the page on how long the effect of botulinum toxin lasts.
Is it reversible?
Yes. The authors of the bite force study describe the reduction as reversible5. As everywhere, the effect of botulinum toxin is temporary: transmission between nerve and muscle gradually recovers, first through small nerve sprouts, then through the return of the original nerve terminal8.
Is there a treatment?
No product reverses the effect of the toxin: the problem goes away on its own over time, usually within a few weeks1,2. In the meantime, adapting what you eat may help.
If you are considering another session, tell the doctor about this problem. In the phase 2b trial, it was slightly more common at the higher dose2, and the single-centre series recommends keeping injection points within a safety zone of the muscle, away from its borders, to limit complications3.
What should you avoid?
- Do not ask for an extra injection to "compensate": muscle weakness may be made worse by another toxin injected before the effect of the previous one has worn off6,7.
- Do not force yourself to eat hard or very fibrous food, or chew gum, while your jaw tires quickly.
- Do not confuse a tired jaw with difficulty swallowing: the latter is a warning sign that requires immediate medical attention7.
When should you see a doctor?
Talk to the doctor who performed the injection if the problem stops you from eating normally, if it comes with significant pain or if it does not improve. Also mention a smile that seems weaker or different: in the phase 2b trial, a few people reported a weak or altered smile2. The page on a changed smile after an injection covers this situation.
More rarely, the toxin can act at a distance from the injection site. The labels then describe difficulty swallowing, speaking or breathing, which requires immediate medical attention6,7. A series of three cases published in 2025 reports one after a masseter injection, with speech and swallowing problems starting 3 days later9. These signs are covered on the page about difficulty swallowing after an injection.
When to seek medical advice quickly
- Difficulty swallowing or breathing
- Changed voice or difficulty speaking clearly
Breathing, swallowing or vision problems: call the emergency services (15 or 112 in France).
Key points
- Weaker chewing or a jaw that tires quickly is the treatment-related side effect most often reported after a masseter injection1,2.
- It usually appears in the weeks after the injection and most often resolves within a few weeks2,4.
- Measured bite force is no longer significantly reduced 6 months after an injection5.
- Treating the masseters is off-label in France; difficulty swallowing, speaking or breathing requires immediate medical attention6,7.
Frequently asked questions
Is it common to have trouble chewing after a masseter injection?
It is the treatment-related side effect most often reported, but how often it occurs depends on how it is recorded. In a manufacturer-funded phase 3 trial, it affected 3.5% of treated people, compared with none on placebo1; in a phase 2b trial, 2.9%2. In a single-centre series, where complaints were noted at every session, a temporary decrease in chewing strength was reported after 30% of sessions3.
Sources
- 1.Sun J. et al., type A botulinum toxin for masseter muscle prominence: placebo-controlled phase 3 trial, Aesthetic Surgery Journal, 2026 (manufacturer-funded study) (opens in a new tab) — Aesthetic Surgery Journal (Oxford University Press)
- 2.Liew S. et al., controlled phase 2b trial of a type A botulinum toxin for masseter muscle prominence, Aesthetic Surgery Journal, 2025 (manufacturer-funded study) (opens in a new tab) — Aesthetic Surgery Journal (Oxford University Press)
- 3.Peng H.P., Peng J.H., complications of botulinum toxin for masseter hypertrophy: incidence over 2,036 treatments, Journal of Cosmetic Dermatology, 2018 (opens in a new tab) — Journal of Cosmetic Dermatology
- 4.Yeh Y.T. et al., literature review of adverse events of botulinum toxin for masseter hypertrophy, Journal of Cosmetic Dermatology, 2018 (opens in a new tab) — Journal of Cosmetic Dermatology
- 5.Ågren M. et al., duration of bite force reduction after a single botulinum toxin injection in the masseter muscles: one-year non-randomised trial, Journal of Oral Rehabilitation, 2023 (partly funded by a manufacturer) (opens in a new tab) — Journal of Oral Rehabilitation
- 6.SmPC of a type A botulinum toxin approved for aesthetic use in France (BDPM, CIS 68150775) (opens in a new tab) — French public medicines database (BDPM)
- 7.Summary of product characteristics of the serotype E botulinum toxin approved in the European Union (EPAR annex I) (opens in a new tab) — European Commission (Union Register of medicinal products)
- 8.de Paiva A. et al., recovery of the neuromuscular junction after botulinum toxin, PNAS, 1999 (opens in a new tab) — Proceedings of the National Academy of Sciences (PNAS)
- 9.Wu L. et al., dysphagia and muscle weakness after cosmetic botulinum toxin injection: three case reports, Dysphagia, 2025 (opens in a new tab) — Dysphagia
- 10.Fedorowicz Z. et al., botulinum toxin for masseter hypertrophy, Cochrane review, 2013 (opens in a new tab) — Cochrane Database of Systematic Reviews